QUality of life and Economic evaluation after neuroSTimulation for Epilepsy
- Conditions
- Epilepsy
- Registration Number
- NL-OMON26320
- Lead Sponsor
- Maastricht University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Medically refractory epilepsy patients indicated for ANT DBS or VNS from january 2021 until january 2026 that will take place in Maastricht UMC+, Amsterdam UMC (location AMC) and Medisch Spectrum Twente.
Exclusion Criteria
Patients without a Dutch language proficiency or with a total IQ score lower than 50.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease specific quality of life
- Secondary Outcome Measures
Name Time Method General quality of life, seizure frequency, care use, productivity